M&A Deal Summary

RSA Acquires Compania de Seguros Generales Cruz del Sur SA

On October 13, 2005, RSA acquired insurance company Compania de Seguros Generales Cruz del Sur SA for 119M USD

Acquisition Highlights
  • This is RSA’s 3rd transaction in the Insurance sector.
  • This is RSA’s 3rd largest (disclosed) transaction.
  • This is RSA’s 2nd transaction in Chile.

M&A Deal Summary

Date 2005-10-13
Target Compania de Seguros Generales Cruz del Sur SA
Sector Insurance
Buyer(s) RSA
Deal Type Add-on Acquisition
Deal Value 119M USD

Target

Compania de Seguros Generales Cruz del Sur SA

Las Condes, Chile
Compania de Seguros Generales Cruz del Sur SA, network with 25 offices, selling through brokers and tied agents. Company predominantly focuses on accident, motor and property and has a 15.8% share of the Chilean general insurance market.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

RSA

London, United Kingdom

Category Company
Sector Insurance
Employees12,378
Revenue 6.9B GBP (2019)
DESCRIPTION

RSA is a multinational quoted insurance group. RSA has core operations in the UK, Scandinavia, Canada, Ireland, and Latin America, and has the capability to write business in around 140 countries. RSA is focusing on general insurance. RSA is based in London, the United Kingdom.


DEAL STATS #
Overall 3 of 17
Sector: Insurance M&A 3 of 17
Type: Add-on Acquisition M&A Deals 2 of 14
Country: Chile M&A 2 of 2
Year: 2005 M&A 2 of 2
Size (of disclosed) 3 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-10-13 La Republica Compania Argentina de Seguros Generales SA

Buenos Aires, Argentina

La Republica Compania Argentina de Seguros Generales SA is a provider of insurance services and is based in Buenos Aires, Argentina.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-08-01 EGI Holdings

Dublin,, Ireland

EGI Holdings is a well established business with strong positions in a number of speciality lines.

Buy €25M